Category: Latest News

  • Cogent Communications Shares Jump Following Wells Fargo Double Upgrade

    Cogent Communications Shares Jump Following Wells Fargo Double Upgrade

    Shares of Cogent Communications (NASDAQ:CCOI) climbed 6.5% on Monday after Wells Fargo analyst Eric Luebchow issued a double upgrade, moving the stock from Underweight to Overweight with a $45 price target. The move bypassed the Neutral rating entirely, shifting straight from a bearish to a bullish outlook, signaling roughly 31% upside from Friday’s close at…

  • Dow Jones, S&P, Nasdaq, Wall Street SFutures et for Slight Pullback After Back-to-Back Gains

    Dow Jones, S&P, Nasdaq, Wall Street SFutures et for Slight Pullback After Back-to-Back Gains

    Futures for major U.S. indexes suggest a slightly lower open on Monday, following two strong weeks that pushed the Nasdaq and S&P 500 to record levels. Traders may use the session to take profits after the recent rally. Market focus is on a high-profile White House meeting involving President Donald Trump, Ukrainian President Volodymyr Zelenskyy,…

  • Empery Digital Slides in Pre-Market Despite Securing Credit Line to Boost BTC Holdings

    Empery Digital Slides in Pre-Market Despite Securing Credit Line to Boost BTC Holdings

    Empery Digital Inc. (NASDAQ:EMPD) shares dropped over 12% in pre-market trading Monday, reaching US$7.90, following the company’s announcement of a US$25 million credit line aimed at funding share repurchases. Over the past year, the stock has plunged more than 90%. Based in Round Rock, Texas, Empery emphasized that the company may draw on the credit…

  • Novo Nordisk Climbs Following FDA Approval of Wegovy for Liver Disease

    Novo Nordisk Climbs Following FDA Approval of Wegovy for Liver Disease

    Shares of Novo Nordisk (NYSE:NVO) rose 2.4% in pre-market trading Monday in New York after the FDA approved Wegovy for treating metabolic dysfunction-associated steatohepatitis (MASH). Previously recognized for its weight-loss benefits, Wegovy now expands its use to address liver disease. The FDA granted accelerated approval, marking Wegovy as the first GLP-1-based therapy indicated for adults…

  • Investors Move to Take Soho House Private in $2.7 Billion Deal

    Investors Move to Take Soho House Private in $2.7 Billion Deal

    A consortium of investors led by MCR Hotels and CEO Tyler Morse has agreed to take Soho House & Co. (NYSE:SHCO) private. MCR owns notable New York properties, including the High Line, Gramercy Park, and other landmark hotels. The deal values the members’ club and hotel operator at around $2.7 billion, including debt. Shareholders are…

  • Pentair to Acquire Hydra-Stop in $290 Million Cash Deal

    Pentair to Acquire Hydra-Stop in $290 Million Cash Deal

    Pentair plc (NYSE:PNR) has signed a definitive agreement to purchase Hydra-Stop LLC, a specialist in valve solutions, from Madison Industries. The deal is valued at roughly $290 million in cash, subject to standard closing adjustments, and could finalize by the end of 2025 pending regulatory approval. After factoring in estimated tax benefits of around $50…

  • Goldman Sachs Strengthens India Footprint with New Mumbai Office

    Goldman Sachs Strengthens India Footprint with New Mumbai Office

    Goldman Sachs (NYSE:GS) has bolstered its operations in India, the world’s fourth-largest economy, by launching a new office in Worli, Mumbai’s premier financial hub. The new facility spans over 6,500 square meters, a 50% increase compared with the bank’s previous Mumbai location. It features modern meeting rooms equipped with Zoom technology, flexible workstations, collaborative spaces,…

  • Thoma Bravo Eyes Dayforce Acquisition, Driving Shares Up

    Thoma Bravo Eyes Dayforce Acquisition, Driving Shares Up

    Shares of Dayforce Inc. (NYSE:DAY) jumped more than 27% in premarket trading Monday, reaching $67.41, after reports surfaced that private equity firm Thoma Bravo (NYSE:TBA) is exploring a potential purchase of the human resources software company. The stock had closed at $52.88 previously. Sources indicate that talks are at an advanced stage, with a possible…

  • Oil Prices Creep Up Ahead of Trump-Zelensky Talks

    Oil Prices Creep Up Ahead of Trump-Zelensky Talks

    Oil prices inched higher on Monday as markets awaited a high-stakes meeting in Washington between U.S. President Donald Trump and Ukrainian President Volodymyr Zelensky, with traders weighing the potential impact on global supply. By 07:45 ET (11:45 GMT), October Brent crude futures rose 0.5% to $66.18 per barrel, while West Texas Intermediate (WTI) futures gained…

  • Nvidia Poised for Another Strong Quarter, Long-Term Outlook Remains Bright: Morgan Stanley

    Nvidia Poised for Another Strong Quarter, Long-Term Outlook Remains Bright: Morgan Stanley

    Morgan Stanley expects Nvidia (NASDAQ:NVDA) to deliver another set of robust results next week, even as expectations remain elevated. The firm lifted its price target to $206 from $200 and kept its Overweight rating in place, emphasizing confidence in the chipmaker’s growth trajectory through 2026. “We expect a strong quarter and outlook, but we’re a…